Healthcare provider profile · identity verified

William Lyle Mcclung, MD

Family Practice · LEXINGTON, VA · NPI 1043214067

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	580	174
Amlodipine Besylate	Amlodipine Besylate	401	121
Levothyroxine Sodium	Levothyroxine Sodium	400	98
Losartan Potassium	Losartan Potassium	380	119
Gabapentin	Gabapentin	327	95
Lisinopril	Lisinopril	303	92
Rosuvastatin Calcium	Rosuvastatin Calcium	253	80
Furosemide	Furosemide	242	73
Omeprazole	Omeprazole	241	79
Metoprolol Succinate	Metoprolol Succinate	229	70
Eliquis	Apixaban	221	50
Metoprolol Tartrate	Metoprolol Tartrate	217	65
Allopurinol	Allopurinol	190	56
Pantoprazole Sodium	Pantoprazole Sodium	190	64
Simvastatin	Simvastatin	190	53
Montelukast Sodium	Montelukast Sodium	186	52
Tamsulosin Hcl	Tamsulosin Hcl	182	58
Tramadol Hcl	Tramadol Hcl	151	41
Hydrochlorothiazide	Hydrochlorothiazide	149	45
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	148	44
Metformin Hcl Er	Metformin Hcl	143	46
Alprazolam	Alprazolam	136	29
Pravastatin Sodium	Pravastatin Sodium	133	38
Metformin Hcl	Metformin Hcl	124	34
Trazodone Hcl	Trazodone Hcl	124	42
Potassium Chloride	Potassium Chloride	121	40
Sertraline Hcl	Sertraline Hcl	119	34
Prednisone	Prednisone	116	74
Farxiga	Dapagliflozin Propanediol	115	25
Atenolol	Atenolol	113	32
Albuterol Sulfate Hfa	Albuterol Sulfate	104	40
Carvedilol	Carvedilol	101	30
Chlorthalidone	Chlorthalidone	97	32
Glipizide Er	Glipizide	93	26
Duloxetine Hcl	Duloxetine Hcl	92	27
Jardiance	Empagliflozin	91	25
Famotidine	Famotidine	90	30
Mirtazapine	Mirtazapine	90	28
Trulicity	Dulaglutide	89	17
Doxycycline Hyclate	Doxycycline Hyclate	84	67
Fluticasone Propionate	Fluticasone Propionate	84	39
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	83	25
Ezetimibe	Ezetimibe	78	26
Clopidogrel	Clopidogrel Bisulfate	76	26
Isosorbide Mononitrate Er	Isosorbide Mononitrate	75	23
Escitalopram Oxalate	Escitalopram Oxalate	74	20
Citalopram Hbr	Citalopram Hydrobromide	69	23
Synthroid	Levothyroxine Sodium	67	17
Buspirone Hcl	Buspirone Hcl	62	20
Donepezil Hcl	Donepezil Hcl	62	23
Spironolactone	Spironolactone	61	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	60	21
Lorazepam	Lorazepam	57	14
Glimepiride	Glimepiride	55	17
Meloxicam	Meloxicam	55	25
Pregabalin	Pregabalin	51	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	21
Warfarin Sodium	Warfarin Sodium	47	15
Doxazosin Mesylate	Doxazosin Mesylate	45	15
Nitroglycerin	Nitroglycerin	45	29
Breo Ellipta	Fluticasone/Vilanterol	44	11
Nystatin	Nystatin	43	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	41	14
Bupropion Xl	Bupropion Hcl	40	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	39	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	38	35
Fluoxetine Hcl	Fluoxetine Hcl	37	11
Mounjaro	Tirzepatide	37	suppressed
Ondansetron Odt	Ondansetron	37	23
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	11
Symbicort	Budesonide/Formoterol Fumarate	37	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	37	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	37	19
Venlafaxine Hcl Er	Venlafaxine Hcl	37	11
Oxycodone Hcl	Oxycodone Hcl	36	suppressed
Clonazepam	Clonazepam	35	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	35	13
Klor-Con M20	Potassium Chloride	34	12
Hydralazine Hcl	Hydralazine Hcl	33	12
Diclofenac Sodium	Diclofenac Sodium	32	suppressed
Azithromycin	Azithromycin	30	19
Finasteride	Finasteride	30	suppressed
Probenecid	Probenecid	30	suppressed
Alendronate Sodium	Alendronate Sodium	29	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	21
Ondansetron Hcl	Ondansetron Hcl	28	suppressed
Benazepril Hcl	Benazepril Hcl	27	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Ozempic	Semaglutide	26	suppressed
Lovastatin	Lovastatin	25	suppressed
Cephalexin	Cephalexin	23	21
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	23	suppressed
Methocarbamol	Methocarbamol	23	suppressed
Terazosin Hcl	Terazosin Hcl	23	suppressed
Torsemide	Torsemide	23	suppressed
Amoxicillin	Amoxicillin	22	15
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Glipizide	Glipizide	22	suppressed
Ipratropium Bromide	Ipratropium Bromide	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Levofloxacin	Levofloxacin	22	18
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	21	suppressed
Colchicine	Colchicine	21	suppressed
Ramipril	Ramipril	21	suppressed
Rybelsus	Semaglutide	21	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Temazepam	Temazepam	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Irbesartan	Irbesartan	19	suppressed
Meclizine Hcl	Meclizine Hcl	18	12
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Xarelto	Rivaroxaban	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Eplerenone	Eplerenone	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Diazepam	Diazepam	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Dofetilide	Dofetilide	12	suppressed
Insulin Lispro	Insulin Lispro	12	suppressed
Megestrol Acetate	Megestrol Acetate	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error